Igc Pharma, Inc. (IGC) — 8-K Filings

8-K Filings (12)

• IGC Pharma Files 8-K Report — Mar 30, 2026 Risk: low
  On March 30, 2026, IGC Pharma, Inc. filed an 8-K report detailing other events and financial statements. The filing includes exhibits such as a graphic image an
• 8-K Filing — Dec 15, 2025
• IGC Pharma Files 8-K on Security Holder Votes & Exhibits — Oct 14, 2025 Risk: low
  IGC Pharma, Inc. filed an 8-K on October 14, 2025, reporting on events that occurred on October 10, 2025. The filing indicates a submission of matters to a vote
• IGC Pharma Files 8-K: Material Agreement & Exhibits — Oct 1, 2025 Risk: medium
  On October 1, 2025, IGC Pharma, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements a
• IGC Pharma Files 8-K — Jun 17, 2025 Risk: low
  IGC Pharma, Inc. filed an 8-K on June 17, 2025, reporting other events and financial statements. The company, formerly known as India Globalization Capital, Inc
• IGC Pharma Files 8-K: Material Agreement, Equity Sales — Sep 27, 2024 Risk: medium
  On September 25, 2024, IGC Pharma, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and f
• IGC Pharma Files 8-K on Security Holder Votes — Aug 27, 2024 Risk: low
  IGC Pharma, Inc. filed an 8-K on August 27, 2024, reporting on matters submitted to a vote of security holders and other events. The filing date for the earlies
• IGC Pharma Enters Loan Agreement, Files 8-K — Aug 2, 2024 Risk: medium
  On July 29, 2024, IGC Pharma, Inc. entered into a material definitive agreement, specifically a loan agreement with an unnamed lender. This agreement creates a
• IGC Pharma Files 8-K with Regulatory Updates — Apr 5, 2024 Risk: low
  IGC Pharma, Inc. filed an 8-K on April 5, 2024, reporting events that occurred on March 20, 2024. The filing includes information related to Regulation FD Discl
• IGC Pharma Files 8-K: Material Agreement, Equity Sales — Mar 28, 2024 Risk: medium
  On March 22, 2024, IGC Pharma, Inc. reported on several key events. The company entered into a material definitive agreement and also disclosed unregistered sal
• IGC Pharma Enters Material Definitive Agreement — Mar 22, 2024 Risk: medium
  On March 19, 2024, IGC Pharma, Inc. entered into a material definitive agreement. The company, formerly known as India Globalization Capital, Inc., filed a Form
• IGC Pharma Appoints New Officers, Clinical Trial Updates — Mar 13, 2024 Risk: medium
  On March 12, 2024, IGC Pharma, Inc. announced the appointment of Dr. Ramana Kumar as Chief Medical Officer and Dr. H.C. Gupta as Chief Scientific Officer. The c

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX